Morgan Stanley
DRTX

Morgan Stanley’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Morgan Stanley’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-41,937
Closed -$531K – 6912
2014
Q3 		$531K Sell
41,937
-50,954
-55% -$761K ﹤0.01% 4527
2014
Q2 		$1.58M Buy
92,891
+68,270
+277% +$1.02M ﹤0.01% 3676
2014
Q1 		$332K Buy
24,621
+18,214
+284% +$239K ﹤0.01% 4831
2013
Q4 		$82K Sell
6,407
-6,960
-52% -$73K ﹤0.01% 5417
2013
Q3 		$121K Buy
+13,367
New +$111K ﹤0.01% 5046

Morgan Stanley's DRTX Position: Q4 2014 in Review

Morgan Stanley sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 41,937 shares — an estimated $531K sold.

Morgan Stanley first reported a position in DRTX in Q3 2013 and held it in 5 quarters. The position peaked at $1.58M in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

  • Morgan Stanley reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Morgan Stanley sold 41,937 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $531K.
  • Morgan Stanley first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q3 2013 and held it in 5 quarters.
  • Morgan Stanley's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $1.58M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Morgan Stanley's 13F filing for Q4 2014, filed 13 Feb 2015.